Finance

Lists
Q2 2026 earnings • in 4 days
See details
MDGL:NASDAQ
Madrigal Pharmaceuticals Inc
$544.51
+0.21%
(+1.16) 1D
Jul 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDGL...
Open
$544.37
High
$547.91
Low
$537.00
Mkt. cap
12.55B
Avg. vol.
382.80K
Volume
147.39K
52-wk high
$615.00
52-wk low
$286.44
EPS
-$12.79
Beta
-1.04
Shares outstanding
23.06M
No. of employees
915
Open
$544.37
High
$547.91
Low
$537.00
Mkt. cap
12.55B
Avg. vol.
382.80K
Volume
147.39K
52-wk high
$615.00
52-wk low
$286.44
EPS
-$12.79
Beta
-1.04
Shares outstanding
23.06M
No. of employees
915
News stories
From sources across the web
About Madrigal Pharmaceuticals Inc
CEOPaul A. Friedman
Employees915
Founded2011
HeadquartersWest Conshohocken, Pennsylvania, United States
SectorBiotechnology
Websitemadrigalpharma.com
Analyst ratings
Based on 12 analysts giving stock ratings to MDGL in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for MDGL in the last 3 months.
Highest
Current $544.51
$964.00 (+77.04%)
Average
$690.55 (+26.82%)
Lowest
$553.00 (+1.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Hold
Reiterated
$553.00
+1.6%
07/22/2026
Ritu Baral
TD Cowen
Buy
Maintained
$644.00
+18.3%
07/20/2026
Ashwani Verma
UBS
Buy
Maintained
$669.00
+22.9%
07/21/2026
Unknown Analyst
UBS
Buy
Maintained
$669.00
+22.9%
07/21/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$739.00
+35.7%
07/17/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
-
-
07/14/2026
Eliana Merle
Barclays
Buy
Maintained
$964.00
+77%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
$600.00
+10.2%
06/30/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$900.00
+65.3%
06/29/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$620.00
+13.9%
05/28/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
$578.00
+6.2%
05/07/2026
Michael DiFiore
Evercore ISI
Buy
Maintained
$649.00
+19.2%
05/07/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$680.00
+24.9%
05/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
$650.00
+19.4%
02/09/2026
Next call in 4 days
Thu, Jul 30, 8:00 AM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$2.23
Revenue / Est. (USD)
- / 352.11M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
212.80M
287.27M
321.08M
311.34M
Cost of goods sold
9.06M
18.12M
24.45M
26.85M
Cost of revenue
9.06M
18.12M
24.45M
26.85M
Research and development expenses
54.08M
174.00M
116.27M
108.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
196.86M
209.12M
239.98M
268.52M
Operating expense
250.94M
383.12M
356.24M
377.21M
Total operating expenses
260.00M
401.24M
380.69M
404.06M
Operating income
-47.20M
-113.98M
-59.61M
-92.72M
Other non operating income
-42.00K
-293.00K
-128.00K
-
EBT including unusual items
-42.28M
-114.19M
-58.58M
-94.39M
EBT excluding unusual items
-42.28M
-111.41M
-58.58M
-94.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42.28M
-114.19M
-58.58M
-94.39M
Net profit margin
-19.87%
-39.75%
-18.24%
-30.32%
Earnings per share
-1.90
-4.96
-2.57
-1.38
Interest and investment income
8.23M
10.31M
9.46M
8.24M
Interest expense
-3.26M
-7.45M
-8.30M
-7.82M
Net interest expenses
4.96M
2.86M
1.16M
424.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.82M
-113.62M
-59.22M
-92.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer